Champions Oncology Reports Q1 Results for Quarter Ended July 31, 2026

What Happened

• On September 10, 2026, Champions Oncology, Inc. (ticker: CSBR) announced unaudited financial results for its first quarter ended July 31, 2026 via a press release.
• The disclosure was filed on Form 8-K under Item 2.02 (Results of Operations and Financial Condition); the press release is attached as Exhibit 99.1 to the filing.

Key Details

• Filing date: September 10, 2026.
• Reporting period: Quarter ended July 31, 2026 (unaudited).
• SEC items: Item 2.02 (results) reported; Exhibit 99.1 (press release) filed under Item 9.01(d).
• No audited financial statements were included in this 8-K (the release summarizes quarterly results).

Why It Matters

• This 8-K is a formal, timely update on Champions Oncology’s quarterly earnings and financial condition; investors should review the attached press release for revenue, profit/loss, cash flow, and any management commentary.
• Because the results are unaudited and presented in a press release, investors should expect more detailed, audited disclosures in subsequent periodic filings (e.g., Form 10-Q) and may watch for management commentary or guidance that could affect the stock.